We sought to determine whether pre-eclampsia, spontaneous preterm birth or the delivery of infants who are small for gestational age were associated with the presence of bacterial DNA in the human placenta. Here we show that there was no evidence for the presence of bacteria in the large majority of placental samples, from both complicated and uncomplicated pregnancies. Almost all signals were related either to the acquisition of bacteria during labour and delivery, or to contamination of laboratory reagents with bacterial DNA. The exception was Streptococcus agalactiae (group B Streptococcus), for which non-contaminant signals were detected in approximately 5% of samples collected before the onset of labour. We conclude that bacterial infection of the placenta is not a common cause of adverse pregnancy outcome and that the human placenta does not have a microbiome, but it does represent a potential site of perinatal acquisition of S. agalactiae, a major cause of neonatal sepsis.
Placental dysfunction is associated with common adverse pregnancy outcomes that determine a substantial proportion of the global burden of disease 1 . However, the cause of placental dysfunction in most cases is unknown. Several studies have used sequencing-based methods for bacterial detection (metagenomics and 16S rRNA gene amplicon sequencing), and have concluded that the placenta is physiologically colonized by a diverse population of bacteria (the 'placental microbiome') and that the nature of this colonization may differ between healthy and complicated pregnancies [2] [3] [4] . This contrasts with the view in the pre-sequencing era that the placenta was normally sterile 5 . However, several studies that applied sequencing-based methods informed by the potential for false-positive results due to contamination [6] [7] [8] have failed to detect a placental microbiome [9] [10] [11] [12] . The aim of the present study was to determine whether pre-eclampsia, delivery of a small for gestational age (SGA) infant and spontaneous preterm birth (PTB) were associated with the presence or a pattern of bacterial DNA in the placenta and to determine whether there was evidence to support the existence of a placental microbiome. We used samples from a large, prospective cohort study of nulliparous pregnant women 13 , and applied an experimental approach informed by the potential for false-positive results 14 .
Experimental approach
We studied two cohorts of patients (Extended Data Fig. 1 and Supplementary Tables 1, 2 ). In cohort 1, babies were all delivered by pre-labour Caesarean section, and the cohort included 20 patients with pre-eclampsia, 20 SGA infants, and 40 matched controls. The placental biopsies were spiked with approximately 1,100 colony-forming units (CFUs) of Salmonella bongori (positive control) and samples were analysed using both deep metagenomic sequencing of total DNA (424 million reads on average per sample) and 16S rRNA gene amplicon sequencing. Cohort 2 included 100 patients with pre-eclampsia, 100 SGA infants, 198 matched controls (two controls were used twice) and 100 preterm births. All of these samples were analysed twice using 16S rRNA gene amplicon sequencing from DNA extracted by two different kits.
Cohort 1: metagenomics and 16S rRNA
The positive control (S. bongori, average 180 reads per sample, Extended Data Fig. 2a ) was detected in all samples. Several other bacterial signals were also observed. Principal component analysis (PCA) (Fig. 1a ) demonstrated that almost all of the variation in the metagenomics data (98%) was represented by principal components 1 (80%) and 2 (18%). This variation was driven by batch effects and not by case-control status ( Fig. 1b ). Any variation that is associated with processing batches, and not the sampling framework, must be due to contamination. A heat map ( Fig. 1c ) showed that eight out of the ten runs had a pronounced Escherichia coli signal (more than 20,000 reads in 64 samples, and 50-150 reads in 16 samples), a large collection of additional bacterial signals, and high levels of PhiX174 reads (group 1; Fig. 1c ). Additional analyses mapping all E. coli reads from all samples together against the closest reference genome (WG5) showed that all E. coli reads belonged to the same strain (Extended Data Fig. 3 ) and are, therefore, due to contamination. All samples belonging to runs 4 and 5 (Fig. 1b ) also had strong Bradyrhizobium and Rhodopseudomonas palustris signals (group 2 in PCA analysis). Runs 8 and 9 (group 3) lacked these strong signals. Two samples had strong human betaherpesvirus 6B (HHV-6B) signals (more than 10,000 read pairs; Fig. 1a-c) , which reflected inheritance of the chromosomally integrated virus, affecting 0.5-1% of individuals in western populations 15 .
We analysed the concordance between metagenomics and 16S rRNA gene amplicon sequencing in 79 samples from cohort 1 ( Table 1 , one 16S primer pair failed). The only signal consistently detected using both methods was S. bongori. An average of approximately 33,000 S. bongori reads (54% of total reads) were found by 16S rRNA amplicon sequencing (Extended Data Fig. 2b ). S. bongori was not detected in the 16S negative controls (DNA extraction blanks; Table 1 ). The level of agreement between metagenomics and 16S rRNA for the other Article reSeArcH bacterial signals was assessed using the kappa statistic, scaled from 0 (no agreement) to 1 (perfect agreement). Only two signals demonstrated agreement (moderate-substantial) between the two methods: S. agalactiae and Deinococcus geothermalis ( Table 1 ). The results were consistent when using different definitions of positive ( Supplementary  Table 3 ) and neither signal was detected in negative controls. The number of positive samples was too small for informative comparison of cases and controls.
Several bacterial signals associated with principal component 2, including the Caulobacter, Methylobacterium and Burkholderia genera, were also detected by 16S rRNA gene sequencing. However, the kappa statistics were low and these signals were also detected in negative controls (Table 1) . Vibrio cholerae and Streptococcus pneumoniae signals were detected using metagenomics in 14 and 11 samples, respectively. However, neither was detected using 16S rRNA sequencing (Table 1) . Assembly and analysis of these reads demonstrated that the closest matches were isolates from Bangladesh (PRJEB14661 V. cholerae) and the Global Pneumococcal Sequence Project (PRJEB31141 S. pneumoniae), which had been sequenced on the same pipelines at the Sanger Institute, indicating that these signals are due to cross-contamination during library preparation or sequencing (the same explanation applies for Leishmania infantum, Fig. 1c ).
Cohort 2: duplicate 16S rRNA
By combining the data from two independent DNA isolation methods (the MP Biomedical kit, hereafter 'Mpbio' , or Qiagen kit), we were able to visualize batch effects using PCA (Extended Data Fig. 5a ) or visualize species individually ( Fig. 1d -g) and analyse signal reproducibility. For example, Bradyrhizobium was detected nearly ubiquitously and in high abundance in some 16S rRNA sequencing runs, but was less frequently detected and in lower abundance in others ( Fig. 1d , compare runs K and L with runs I and J). The Burkholderia genus, which has been suggested to have a role in PTB 3 , had a higher signal in samples isolated using the Mpbio DNA isolation reagents than with the Qiagen kit, and also showed pronounced run-to-run variation (Fig. 1e ). Furthermore, both Bradyrhizobium and Burkholderia were commonly detected in 
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the negative controls. Batch effects based on the use of particular polymerase chain reaction (PCR) reagent lots can also be visualized. For example, the association of Thiohalocapsa halophila with either the PCR reagent '5× Q5 buffer' (lot 11408) or 'Q5 Taq polymerase' (lot 51405), both of which were used to process the same 390 samples, is shown in Fig. 1f . We used the kappa statistic to quantify the level of agreement between 16S rRNA amplicon sequencing of two DNA samples from Fig. 6 for scatterplots. Percentage read count is based on the higher value for given species using Qiagen or Mpbio DNA isolation kit (using all 498 samples). the same patient extracted using the two different kits (Supplementary Table 4 ). The majority of the most-prevalent bacterial groups had low kappa scores and there was a low correlation between the magnitude of the signals comparing the two DNA extraction methods (Extended Data Fig. 5b ). Moreover, these signals also demonstrated notable batch effects using PCA (Extended Data Fig. 5a ). Interestingly, four ecologically unexpected bacterial groups of high prevalence exhibited a fair level of concordance (Rhodococcus fascians, Sphingobium rhizovicinum, Methylobacterium organophilum and D. geothermalis). Further analysis demonstrated a temporal pattern of these signals (Fig. 1g ). All placental samples were washed in sterile PBS to remove surface contamination, such as maternal blood, and the temporal pattern of these bacterial signals is consistent with them being derived from batches of this reagent. Some ecologically plausible species, such as S. agalactiae and Listeria monocytogenes, vaginal lactobacilli, vaginosis-associated bacteria, faecal bacteria and some bacteria of probable oral origin had modest to high kappa scores, indicating that they were sample-associated signals. In contrast to the laboratory contaminants, the signals for these bacterial groups correlated when comparing the two DNA extraction methods ( Fig. 2a ) and were not associated with batch effects identifiable using PCA. Sample-associated signals (non-reagent contaminants) of a few species not typically associated with a vaginal or rectal habitat but with the oral habitat were detected, such as Streptococcus mitis, Streptococcus vestibularis and Fusobacterium nucleatum. However, it was only a very small minority of samples that exhibited these signals (below that of S. agalactiae) and none of these oral signals was identified by metagenomic analysis of pre-labour Caesarean section samples (cohort 1).

Capable pathogens
Streptococcus agalactiae
✓ ✓ ✓ ✓ ✓ ✓ Listeria monocytogenes f ✓ ✓ ✓ ✓ ✓ − Vaginal lactobacilli Lactobacillus crispatus ✓ ✓ −~✓L actobacillus iners ✓ ✓ −~✓ − Lactobacillus gasseri ✓ ✓ − ✓ ✓ − Lactobacillus jensenii ✓ ✓ −~✓ − Vaginosis-associated bacteria Gardnerella vaginalis ✓ ✓ −~✓ − Atopobium vaginae ✓ ✓ −~✓ − Ureaplasma (genus) ✓ ✓ − ✓ ✓ − Prevotella bivia ✓ ✓ −~✓ − Prevotella amnii ✓ ✓ − ✓ ✓ − Prevotella timonensis ✓ ✓ −~✓ − Aerococcus christensenii ✓ ✓ − ✓ ✓ − Streptococcus anginosus ✓ ✓ −~✓ − Sneathia sanguinegens ✓ ✓ − ✓ ✓ − Megasphaera elsdenii ✓ ✓ −~✓ − Faecal-associated bacteria Bacteroides (genus) ✓ ✓ −~✓ − Faecalibacterium prausnitzii ✓ ✓ −~✓ − Roseburia faeces − ✓ −~✓&− − Coriobacterium sp. ✓ ✓ −~✓ − Collinsella intestinalis ✓ ✓ − + ✓ − Suspected oral origin Fusobacterium nucleatum ✓ ✓ ✓~✓ − Streptococcus mitis ✓ ✓ ✓~✓ − Streptococcus vestibularis − ✓ ✓~✓&− − Genuine reagent contaminants Acinetobacter baumanii f − ✓ ✓~−T hiohalocapsa halophila − ✓ ✓ − − − Propionibacterium acnes − ✓ ✓ − − − Stenotrophomonas maltophilia − ✓ ✓ − − − Bradyrhizobium japonicum − ✓ ✓ − − − Melioribacter roseus − ✓ ✓ − − − Pelomonas (genus) − ✓ ✓ − − − Methylobacterium (genus) − ✓ ✓ − − − Aquabacterium (genus) − ✓ ✓ − − − Sediminibacterium (genus) − ✓ ✓ − − − Desulfovibrio alkalitolerans − ✓ ✓ − − − Delftia tsuruhatensis − ✓ ✓ − − − Streptococcus pyogenes − ✓ ✓~− − Burkholderia multivorans − ✓ ✓ − − − Caulobacter (genus) − ✓ ✓ − − − Steroidobacter sp. JC2953 − ✓ ✓ − − − Afipia (genus) − ✓ ✓ − − − Burkholderia silvatlantica − ✓ ✓ − − − Lysinimicrobium mangrove − ✓ ✓ − − − Bradyrhizobium elkanii − ✓ ✓ − − − Achromobacter xylosoxidans − ✓ ✓ − − − Corynebacterium tuberculostearicum − ✓ ✓ − − − Rhodococcus fascians ✓ − ✓~✓ − Sphingobium rhizovicinum ✓ − ✓~✓ − Methylobacterium organophilum ✓ − ✓~✓ − Deinococcus geothermalis f ✓ − ✓ ✓ ✓
Delivery-associated signals
Vaginal organisms (lactobacilli and vaginosis-associated bacteria) were more abundant than S. agalactiae in cohort 2 (vaginal, intrapartum and pre-labour Caesarean section deliveries) but less abundant than S. agalactiae in cohort 1 (pre-labour Caesarean section deliveries only). Hence, we next examined the relationship between the mode of delivery and the 16S rRNA signal. Vaginal lactobacilli (Lactobacillus iners, Lactobacillus crispatus, Lactobacillus gasseri and Lactobacillus jensenii) were found more frequently and in higher numbers in vaginally delivered placentas than in placentas delivered via intrapartum or pre-labour Caesarean section ( Fig. 2b) , irrespective of the DNA isolation method (Extended Data Fig. 7a, b ). Vaginosis-associated bacteria were found at approximately the same frequency in vaginal and intrapartum Caesarean section samples, but significantly less frequently in pre-labour Caesarean section samples ( Fig. 2c ). A heat map generated using the Spearman rho correlation coefficients of all abundant and relevant bacterial groups generated a cluster of vaginally associated bacteria, representative of vaginal community group IV 16 , which reflects sample contamination during labour and delivery (Extended Data Fig. 8 ).
The other clusters represented the contamination signatures of the two different DNA extraction kits and a fourth cluster reflected contamination associated with the date of collection of the placental biopsies (2012-2013).
Genuine signals and pregnancy outcome
The presence of S. agalactiae was analysed with respect to clinical outcome (SGA, pre-eclampsia, PTB) as it was the only organism that met all of the criteria of a genuine placenta-associated bacterial signal (Table 2 ). There was no association with SGA, pre-eclampsia or PTB ( Fig. 3 ). Exploratory analysis of the 16S amplicon sequencing data of all sample-associated signals, including delivery-associated bacteria, showed that S. mitis and F. nucleatum were not associated with adverse pregnancy outcome (Supplementary Table 5 ). Of note, however, were the significant associations of the delivery-associated bacteria L. iners with pre-eclampsia and Streptococcus anginosus and the Ureaplasma genus with PTB ( Fig. 3 , Supplementary Table 5 and Extended Data Fig. 9 ). In one placental sample from a preterm birth, a strong L. monocytogenes signal was found (7% and 52% of all reads with Mpbio and Qiagen, respectively).
Validating Streptococcus agalactiae
A nested PCR and quantitative PCR (qPCR) approach targeted towards the sip gene, which encodes the surface immunogenic protein (SIP) of S. agalactiae, was used to verify its presence in 276 placental samples for which a 16S sequencing result was available. In total, 7 out of 276 samples were positive using PCR-qPCR and all seven were also positive (more than 1%) by 16S analysis. A total of 14 samples were positive by 16S sequencing but not by PCR-qPCR, no sample was positive using PCR-qPCR and negative by 16S, and 255 samples were negative by both methods. This yielded a kappa statistic of 0.48, indicating moderate agreement and a P value of 9.7 × 10 −21 . We conclude that the detection of S. agalactiae by 16S rRNA amplification was verified by two further independent methods (metagenomics and PCR-qPCR) and the level of agreement in both cases was well above what could be expected by chance. It remains to be determined why some samples were positive for S. agalactiae by 16S sequencing but negative by the PCR-qPCR method. Generally, the latter would be considered more sensitive, particularly in samples with a higher microbial biomass, owing to the complex amplification kinetics when a large number of diverse 16S template molecules are present. However, in the absence of other bacterial signals, it is possible that 16S sequencing is more sensitive for detecting very small numbers of S. agalactiae, as the genome of the organism has seven copies of the 16S rRNA gene, but only one copy of sip 17 .
Discussion
We studied placental biopsies from a total of 537 women, including 318 cases of adverse pregnancy outcome and 219 controls, using multiple methods of DNA extraction and detection, and drew several important conclusions. First, we found that the biomass of bacterial sequences in DNA extracted from human placenta was extremely small. Second, the major source of bacterial DNA in the samples studied was contamination from laboratory reagents and equipment. Third, both metagenomics and 16S amplicon sequencing were capable of detecting a very low amount of a spiked-in signal. Fourth, samples of placental tissue Article reSeArcH become contaminated during the process of labour and delivery, even when they were dissected from within the placenta. Finally, the only organism for which there was strong evidence that it was present in the placenta before the onset of labour was S. agalactiae. It was not part of any batch effect, it was detected by three methods, there was a statistically significant level of agreement between 16S amplicon sequencing and both metagenomics (P = 1.5 × 10 −8 ) and a targeted PCR-qPCR assay (P = 9.7 × 10 −21 ), none of 47 negative controls analysed by 16S sequencing was positive for S. agalactiae, and there was no association with mode of delivery (Extended Data Fig. 7 ). However, there was no significant association between the presence of the organism and pre-eclampsia, SGA or PTB. Exploratory analysis of other signals did demonstrate an association between PTB and the presence of Ureaplasma reads (>1%), consistent with previous studies 18 , but this was probably the result of ascending uterine infection. We conclude that bacterial placental infection is not a major cause of placentally related complications of human pregnancy and that the human placenta does not have a resident microbiome.
The finding of S. agalactiae in the placenta before labour could be of considerable clinical importance. Perinatal transmission of S. agalactiae from the mother's genital tract can lead to fatal sepsis in the infant. It is estimated that routine screening of all pregnant women for the presence of S. agalactiae and targeted use of antibiotics prevents 200 neonatal deaths per year in the United States 19 . Our findings identify an alternative route for perinatal acquisition of S. agalactiae. Further studies will be required to determine the association between the presence of the organism in the placenta and fetal or neonatal disease. However, if such a link was identified, rapid testing of the placenta for the presence of S. agalactiae might allow targeting of neonatal investigation and treatment. Our work also sheds light on the possible routes of fetal colonization. Although we see no evidence of a placental microbiome, the frequency of detection of vaginal bacteria in the placenta increased after intrapartum Caesarean section, suggesting ascending or haematogenous spread. Similarly, haematogenous spread as the result of transient bacteraemia could potentially explain the presence of the small number of sample-associated oral bacterial signals 14 . Such spread could lead to fetal colonization immediately before delivery.
We identified five different patterns of contamination ( Fig. 4) namely, contamination of the placenta with real bacteria during the process of labour and delivery (Fig. 2) ; contamination of the biopsy when it was washed with PBS; contamination of DNA during the extraction process; contamination of reagents used to amplify the DNA before sequencing; and contamination from the reagents or equipment used for sequencing. Using 16S rRNA amplicon sequencing, the positive control (S. bongori) accounted for more than half of the reads, indicating that the method is highly sensitive. However, when the method is applied to samples with little or no biomass, these sources of contamination can lead to apparent signals, hence it is crucial to use a method that allows differentiation between true bacterial signals and these sources of contamination (see Supplementary Information 1 for further technical discussion).
In conclusion, in a study of 537 placentas carefully collected, processed and analysed to detect real bacterial signals, we found no evidence to support the existence of a placental microbiome and no significant relationship between placental infection with bacteria and the risk of pre-eclampsia, SGA and preterm birth. However, we identified an important pathogen, S. agalactiae, in the placenta of approximately 5% of women before the onset of labour.
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MeThodS
Ethics. This study is in compliance with all relevant ethical regulations. The Pregnancy Outcome Prediction study (POPs) was approved by the Cambridgeshire 2 Research Ethics Committee (reference number 07/H0308/163). The study and the characteristics of the eligible and participating women have been previously described in detail 13, 20 . In brief, 4,212 nulliparous women with a singleton pregnancy were followed through from their first ultrasound scan to delivery. At the time of delivery, placental samples were obtained using a standardized protocol by a team of trained technicians, in which most samples were obtained within 3 h of delivery (interquartile range: 0.3-8.4 h). All participants gave written informed consent for the study and for subsequent analysis of their samples. Supplementary Table 1 .
For cohort 2, cases of SGA (≤fifth customized birth weight percentile 21 ; n = 100) or pre-eclampsia (2013 ACOG guidelines 22 ; n = 100) were selected. The cases were matched one-to-one with healthy controls (n = 198, two controls were used twice). All deliveries were at term (≥37 weeks gestation). The same matching criteria as in the first cohort were used with the addition of an absolute match for mode of delivery. Placentas from 100 preterm births (<37 weeks gestation) deliveries were also included in the study (clinical characteristics in Supplementary  Table 2 ). Flow charts describing the two cohorts and subsequent sample-processing and analysis steps are presented in Extended Data Fig. 1 . Placenta collection. Placentas were collected after delivery and the procedure has previously been described in detail 20 . We confined our sampling to the placental terminal villi (fetal tissue). We chose this as the villi are the site of exchange, across the vasculosyncytial membrane, between the fetus and mother. This location is the closest interface between the fetus with the mother's blood and tissues. If the placenta was colonized, one would expect bacteria to ascend the genital tract (local infiltration) or to come from the mother's blood (haematogenous). Hence, we believe that this would be the most plausible site for bacteria to be found. Villous tissue was obtained from four separate lobules of the placenta after trimming to remove adhering decidua from the basal plate. The tissue in the selected areas had no visible damage, haematomas, or infarctions. To remove maternal blood, the selected tissue samples were rinsed in chilled sterile PBS (Oxoid Phosphate Buffered Saline Tablets, Dulbecco A; Thermo Fisher Scientific) dissolved in ultrapure water (ELGA Purelab Classic 18MΩ.cm). After initial collection, all placental samples were frozen in liquid nitrogen and stored at −80 °C until further processing. For DNA isolation, approximately 25 mg of villous tissue (combined weight obtained from fragments of all four biopsy collection points) was cut from the stored tissue. To reduce the risk of environmental contamination of the samples, the entire experimental procedure was carried out in a class 2 biological safety cabinet (tissue cutting, DNA isolation, setting up PCR reactions). The tissue was cut with single-use sterile forceps and scalpel. Each matched case-control pair was processed in parallel on the same day for each step of the entire experimental procedure (tissue cutting, DNA isolation, setting up PCR reactions). Also, the same lot of laboratory reagents was used for each pair. For each lot of laboratory reagents, negative controls were included (described in detail below). DNA isolation from cohort 1. DNA was isolated from placental tissue with the Qiagen Qiaamp DNA mini kit (51304; Qiagen) according to the manufacturer's instructions with the addition of a freeze-thaw cycle after the overnight tissue lysis. Before DNA isolation, intact S. bongori was added to the placental tissue (1,100 CFUs, described in detail below). The placental tissue with added S. bongori was lysed in a proteinase-K-based solution (100 µl buffer ATL (Qiagen), 80 µl of S. bongori, 20 µl proteinase K) overnight (18 h at 56 °C) and thereafter freezethawed once. After the thawed samples were brought to room temperature, RNA was removed with the addition of 4 µl RNase A (Qiagen, 19101) and incubated at room temperature for 2 min. Spin-filtering and washing of the DNA was carried out according to the manufacturer's instructions. The DNA was eluted from the spin column with 200 µl buffer AE (Qiagen) after a 5 min incubation (the elution step was repeated once with another 200 µl buffer AE and 5 min incubation). To prevent accidental cross-contamination between samples, gloves were changed between handling each sample. Throughout the protocol (DNA extraction, primer aliquoting, 16S rRNA gene amplification and library preparation), nuclease-free plastics were used (unless supplied with kit): PCR clean 2.0 and 1.5 ml DNA LoBind Tubes (Eppendorf), and nuclease-free filter tips (TipONE sterile filter tips, STARLAB). For each box of DNA isolation kit used, extraction blanks were carried out. These DNA extraction blanks, or negative controls, contained only the reagents from each DNA isolation kit (no added biological material) and were subjected to the complete DNA extraction procedure: tissue homogenization, matrix binding, spin-filtering, washing, and elution of nucleic acids. The negative controls were subjected to the entire analysis protocol alongside the placental samples: DNA isolation, 16S rRNA gene PCR amplification, sequencing and data analysis. Positive control. As a positive control, a known amount of intact S. bongori (strain NCTC-12419) was added to each of the placental tissue samples in cohort 1 before DNA isolation (n = 80). S. bongori was incubated with shaking overnight at 37 °C in LB broth. When the OD 600 reached 0.9 (approximately equivalent to 7.2 × 10 8 bacteria per ml, measured with a Ultrospec 10 Cell Density Meter, GE Healthcare) the culture was chilled on ice. To minimize bacterial growth outside of the shaking incubator, all cultures and dilutions were kept on ice. To increase the proportion of live bacteria added as positive controls, 1 ml of the S. bongori suspension was diluted in 14 ml fresh LB broth (OD 600 was 0.06) and incubated with shaking (1.5 h at 37 °C; OD 600 was 0.8). The S. bongori culture was then serially diluted to an estimated concentration of 1,000 S. bongori per 80 µl, which was used to spike the placental samples. To determine the actual number of CFUs added to the placental samples, the S. bongori suspension was further diluted and aliquots cultured on LB plates overnight (37 °C). The number of colonies was counted. On the basis of three plates with distinct individual colonies (between 29 and 205 colonies per plate), the number of S. bongori added to each placental tissue sample was calculated to be 1,100 CFUs. DNA isolation from cohort 2. DNA was isolated twice from each placenta using two different extraction kits. The DNA isolations were carried out in accordance with respective manufacturer's instructions, with the addition of two extra washes in the MP Biomedical kit.
For the Qiagen Qiaamp DNA mini kit (Qiagen, 51304), the placental tissue was digested in a proteinase-K-based solution (100 µl buffer ATL, 80 µl PBS, 20 µl proteinase K) for at least 3 h. Then, 4 µl of RNase A (Qiagen, 19101) was added to the tissue lysate and incubated at room temperature for 2 min. Spin-filtering and washing of the DNA was carried out according to the manufacturer's instructions. The DNA was eluted from the spin column with 200 µl buffer AE after a 5 min incubation (the elution step was repeated once with another 200 µl buffer AE and 5 min incubation).
For the MP Biomedical Fast DNA Spin kit (MP Biomedical, 116540600), the placental tissue was homogenized in 1.0 ml of CLS-TC solution by bead-beating (Lysing Matrix A tubes, 40 s, speed 6.0 on a FastPrep-24, MP Biomedical). After spinning the samples, equal volumes of the supernatant were combined with Binding Matrix. The mixture was transferred to a spin filter, after spin filtering the DNA was washed three times with SEWS-M. The DNA was eluted by re-suspending the Binding Matrix in 100 µl DES buffer, incubating the tubes at 55 °C for 5 min before recovering the DNA by centrifugation.
The same measures to prevent contamination of the samples as described in the cohort 1 DNA isolation section were taken. Extraction blanks were generated for each box/lot of both DNA isolation kits in a similar manner as was done for cohort 1. DNA concentrations were determined by Nanodrop Lite (Thermo Fisher Scientific). Metagenomic sequencing. Sample processing for the metagenomics analysis was performed exactly as previously described 23 . In brief, the NEB Ultra II custom kit (New England Biolabs) was used for library generation, and samples were then sequenced on the Illumina HiSeq X Ten platform (150 base pairs, paired end) in 10 runs (flowcells) of 8 samples (lanes) each. The sequencing coverage was designed to generate more than 30-fold coverage of the human chromosomal DNA in each sample. 16S rRNA gene amplification. For detection of the bacterial 16S rRNA gene, PCR amplification of the V1-V2 region was performed using V1 primers with four degenerate positions to optimize coverage as previously recommended 24 . The V1-V2 amplicon is relatively short (~260 bp) and, with paired-end reads, almost all of the amplified product is sequenced on both strands and thus at higher accuracy. This is not the case with the longer V1-V3 amplicon. This region has also been used in other studies of the placental microbiome 10 . The following barcoded primers were used forward-27: 5′-AATGATACGGCGACCACCGAGATCTACACnnnnnnnnnnnnACACTCTTT CCCTACACGACGCTCTTCCGATCTNNNNAGMGTTYGATYMTGGCTCA G-3′ and reverse-338: 5′-CAAGCAGAAGACGGCATACGAGAT nnnnnnnnnnnn GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNG CTGCCTCCC GTAGGAGT. The n-string represents unique 12-mer barcodes used for each sample studied and distinct indexes were used at both the 5′ and 3′ ends of the amplicons. The primers were purchased from Eurofins Genomics. Before aliquoting, the cabinet and pipettes were cleaned with DNA AWAY Surface Decontaminant. The primers were diluted in Tris-EDTA buffer (Sigma-Aldrich) in PCR clean nuclease-free DNA LoBind Tubes (Eppendorf) with nuclease-free filter tips (TipONE sterile filter tips, STARLAB). The PCR amplification was carried out in quadruplicate reactions for each sample on a SureCycler 8800 Thermal Cyc ler (Agilent Technologies) with high-fidelity Q5 polymerase (M0491L; New
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England Biolabs), dNTP solution mix (N0447L, New England Biolabs), and UltraPure DNase/RNase-Free Water (Thermo Fisher Scientific) in 0.2 ml PCR strips (STARLAB). Amplification was performed with 500 ng DNA per reaction, and the final primer concentration was 0.5 µM. The PCR amplification profile was an initial step of 98 °C for 2 min followed by 10 cycles of touch-down (68 to 59 °C; 30 s), and 72 °C (90 s), followed by 30 cycles of 98 °C (30 s), 59 °C (30 s), and 72 °C (90 s). After completion of cycling, the reactions were incubated for 5 min at 72 °C. After completion of the PCR, the four replicates of each sample were pooled, cleaned up with AMPure XP beads (A63881; Beckman Coulter) and eluted in Tris-EDTA buffer (Sigma-Aldrich). DNA concentration was determined by Qubit Fluorometric Quantitation (Q32854; Invitrogen). Equimolar pools of the PCR amplicons were run on 1% agarose/TBE gels and ethidium bromide used to visualize the DNA. The DNA bands were excised and cleaned up with a Wizard SV Gel and PCR Clean-Up System (Promega UK). The equimolar pools were sequenced on the Illumina MiSeq platform using paired-end 250 cycle MiSeq Reagent Kit V2 (Illumina). Bioinformatic analysis of metagenomics data. Bioinformatic analysis first required removal of human reads followed by identification of the species of non-human reads. KneadData (http://huttenhower.sph.harvard.edu/kneaddata) is a tool designed to perform quality control on metagenomic sequencing data, especially data from microbiome experiments, and we used this to remove the human reads. Forward and reverse reads from each sample were filtered using KneadData (v.0.6.1) with the following trimmomatic options: HEADCROP9, SLIDINGWINDOW:4:20, MINLEN: 100. A custom Kraken 25 reference database (v.0.10.6) was built, using metagm_build_kraken_db and -max_db_size 30, to detect any bacterial, viral and potential non-human eukaryotic signals. This custom Kraken reference database included both the default bacterial and viral libraries, and an accessions.txt file was supplied (via -ids_file) containing a diverse array of organisms chosen from all sequenced forms of eukaryotic life (see Supplementary  Table 6 for accession numbers). This wide array was chosen to both detect potentially relevant unknown organisms, but also to identify additional human reads that had not been mapped to the human reference genome. In the metagenomic data, various non-human eukaryotic signals were identified by Kraken in every placental sample at a similar percentage, and were mostly assigned to Pan paniscus (Supplementary Table 6 ). As a verification, reads mapping to eukaryotic species were extracted (Supplementary Information 1) and contigs were assembled. These were analysed using BLASTN and were indeed identified as human. This indicates that these (often lower quality or repetitive) eukaryotic reads are in fact human reads that were not removed by mapping against the human reference genome. An exception to this was that in 17 samples an elevated number of reads were assigned to Danio rerio (zebrafish) and Sarcophilus harrisii (Tasmanian devil), both of which had been sequenced on the Sanger Institute pipeline. Kraken was run using the metagm_run_kraken option. All human-derived signals (eukaryotic non-fungal reads found in every placental sample at a similar percentage) were removed before further analysis. See Source Data of Fig. 1a -c for abundance information. The origins of Streptococcus pneumonia and Vibrio cholerae reads were analysed by extracting their respective reads as identified by the Kraken using custom scripts ( Supplementary Information 1) , performing an assembly on these reads using Spades (v.3.11.0) 26 and by using BLAST (blastn, database: others) 27 to find the closest match. The first step of the strain level analysis of E. coli reads to find the closest E. coli reference genome match was identical to the steps described above. Subsequently, E. coli reads were mapped against E. coli WG5 (GenBank: CP02409.1) using BWA (v.0.7.17-r1188) 28 and visualized using Artemis (v.16.0.0) 29 . E. coli reads were both analysed per sample and by combining all E. coli reads from all samples together. Bioinformatic analysis of 16S rRNA gene amplicon data. To analyse all 14 16S rRNA amplicon data together using the MOTHUR (v.1.40.5) MiSeq SOP 30 and the Oligotyping (v.2.1) pipeline 31 , the data from each individual run were initially individually processed in the MOTHUR pipeline as described below. All of the reads need to be aligned together as a requirement of the Oligotyping pipeline so after the most memory intensive-filtering steps had been performed, they were combined and processed again. Modifications to the MOTHUR MiSeq SOP are as follows: the 'make.contigs' command was used with no extra parameters on each individual run. The assembled contigs were taken out from the MOTHUR pipeline and the four poly NNNNs present in the adaptor/primer sequences were removed using the '-trim_left 4' and '-trim_right 4' parameters in the PRINSEQlite (v.0.20.3) program 32 . The PRINSEQ trimmed sequences were used for the first 'screen.seqs' command to remove ambiguous sequences and sequences containing homopolymers longer than 6 bp. In addition, any sequences longer than 450 bp or shorter than 200 bp were removed. Unique reads ('unique.seqs') were aligned ('align.seqs') using the Silva bacterial database 'silva.nr_v123.align' 33 with flip parameter set to true. Any sequences outside the expected alignment coordinates ('start=1046' , 'end=6421') were removed. The correctly aligned sequences were subsequently filtered ('filter.seqs') with 'vertical=T' and 'trump=' . The filtered sequences were de-noised by allowing three mismatches in the "pre.clustering" step and chimaeras were removed using Uchime with the dereplicate option set to 'true' . The chimaera-free sequences were classified using the Silva reference database 'silva.nr_v123.align' and the Silva taxonomy database 'silva.nr_v123.tax' and a cut-off value of 80%. Chloroplast, mitochondria, unknown, archaea, and eukaryota sequences were removed. All reads from each sample were subsequently renamed, placing the sample name of each read in front of the read name. The 'deunique.seqs' command, which creates a redundant fasta file from a fasta and name file, was performed before concatenating all of the data of all 14 16S runs together using the 'merge.files' command, which was done on both the fasta and the group files. The 'unique.seqs' command was again used before again aligning all reads as described previously before finishing the MOTHUR pipeline with the 'deunique.seqs' command. Oligotyping and species identification. After the MOTHUR pipeline, the redundant fasta file, which now only contains high-quality aligned fasta reads, was subsequently used for oligotyping using the unsupervised minimum entropy decomposition (MED) for sensitive partitioning of high-throughput marker gene sequences 31 . A minimum substantive abundance of an oligotype (-M) was defined at 1,000 reads and a maximum variation allowed (-V) was set at 3 using the command line 'decompose 14runs.fasta -M 1000 -V 3 -g -t' . The node representative sequence of each oligotype (OTP) was used for species profiling using the ARB program (v.5.5-org-9167) 34 . For ARB analysis, we used a customized version of the SILVA SSU Ref database (NR99, release 123) that was generated by removing uncultured taxa. Oligotype abundances are provided in Supplementary Information 2 and additional metadata, for example, contamination identification via PCA (Extended Data Fig. 3 ), is provided in the Source Data. Sensitivity analysis. To compare 16S rRNA amplicon sequencing and metagenomics sensitivity, the S. bongori signals (positive control) spiked into cohort 1 were analysed (Extended Data Fig. 2a, b ). In 16S rRNA amplicon sequencing analysis 1,100 CFUs of S. bongori resulted in an average of 33,000 S. bongori reads (~54%). Thus, the remaining bacterial signal (reagent contamination background plus other signals) contributes the remaining 46% of the reads. This is approximately equivalent to another 937 S. bongori CFUs (1,100/(54/46)). Thus, if there are 937 bacteria in the sample (everything except the spike), this should produce a signal of 100% when there are no spiked-in bacteria present. Thus, the sensitivity of this assay in cohort 2, which did not contain a spike, is 0.106% of sequencing reads per CFUs (100%/937 CFUs). However, although an average of 54% S. bongori reads were detected in all spiked samples, it can be reasoned that samples with the highest S. bongori percentages only have reagent contamination DNA to compete with during the PCR step and not any other sample-associated signals. S. bongori percentages in the top 20th percentile on average account for 71% of all reads, which would correspond to a sensitivity limit of ~0.2% of reads per CFU (100/(1,100/(71/29)). However, a threshold of 1%, as previously used 9 , can be considered a more reliable cut-off for determining whether a signal should be considered biologically relevant. A threshold of 1% would be indicative of multiple replication events (more than 2) and thus metabolic activity or repeated invasion of the tissue by the respective organism. In addition, a 1% threshold for the 16S rRNA data is comparable with the sensitivity of metagenomics as on average 180 S. bongori read pairs were detected with metagenomics (Extended Data Fig. 2a ). In contrast to 16S analysis, the S. bongori spike has no meaningful effect on quantification in metagenomics as microorganisms only represent a very small fraction of the total amount of reads (the vast majority of reads are human). Hence, 6 CFUs are required on average per metagenomics read pair and 6 CFUs would result in a signal of approximately 1% of 16S amplicon reads in cohort 2 using the Qiagen kit. Nested PCR. We developed a nested PCR assay to sensitively detect the S. agalactiae sip gene. In total, 276 placental DNA samples (isolated with the Qiagen kit as described above) were used of which 226 had no (0%) S. agalactiae reads detected by 16S rRNA gene sequencing, while S. agalactiae reads were detected in 50 samples (range 0.002-63.37% of 16S rRNA reads). The first-round PCR was performed using the DreamTaq PCR Master Mix (2×) (K1071; Thermo Fisher Scientific) and the following primers for the sip gene at a final concentration of 0.5 µM: forward 5′-TGAAAATGAATAAAAAGGTACTATTGACAT-3′ and reverse 5′-AAGCTGGCGCAGAAGAATA-3′. Amplification was performed in 50-µl aliquots and using 500 ng of placental DNA per reaction. Genomic S. agalactiae DNA (ATCC BAA-611DQ) was used as positive control at 20 or 2 copies per reaction. One reaction was set up with water instead of gDNA as negative control. The PCR amplification profile had an initial step of 95 °C for 3 min followed by 15 cycles of 95 °C (30 s), 48 °C (30 s), and 72 °C (60 s). After completion of cycling, the reactions were incubated for 3 min at 72 °C. The second-round qPCR was performed using the TaqMan Multiplex Master Mix (4461882; Thermo Fisher Scientific) and two TaqMan Assays (Thermo Fisher Scientific): Ba04646276_s1 (Gene Symbol: SIP; Dye Label, Assay Concentration: FAM-MGB, 20×) at a final 1× concentration; RNase P TaqMan assay (ABY dye/QSY probe Thermo Fisher Scientific 4485714) at a final 0.5× concentration, added as a positive control for the human DNA. In each well, 6 µl of the first-round PCR (or water in the no template control/blank wells) was used as the reaction substrate in a total volume of 15 µl. The PCR amplification profile had an initial step of 95 °C for 20 s followed by 40 cycles of 95 °C (5 s) and 60 °C (20 s). Statistics. The inter-rater agreement kappa scores 35 and P values were computed by DAG_Stat 36 . Comparison of cases and controls was performed using multivariable logistic regression, with conditional logistic regression employed for paired comparisons, using Stata v.15.1 (Statacorp). Other statistical calculations were performed in GraphPad Prism 7 (GraphPad Software). PCAs were performed with the prcomp function from the R package in RStudio (v.0.99.902) with all settings, where applicable, set to 'true' . As the effect size was not known in advance, we performed power calculations with varying prevalence and effect sizes (odds ratio) for 100 case-control pairs (pre-eclampsia and growth restriction) used in the 16S rRNA amplicon sequencing study. These showed that a 5% prevalence in controls and OR = 5 gives 82% power to detect the signal at significance level 0.05. The bioinformatic analysis and the setting of the minimum detection thresholds were performed in a blinded fashion in respect to adverse pregnancy outcome status. All reported P values are two-sided except for concordance calculations, as indicated. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment unless described otherwise. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Last updated by author(s): May 30, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
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Policy information about availability of computer code
Data collection
The only software used to collect data was the standard MiSeq and HiSeq (Illumina) sequencing machine software and the quantitative PCR machine software (QuantStudio 6 Flex system, ThermoFisher Scientific).
Data analysis
KneadData (v0.6.1), Kraken (v0. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
The 16S rRNA gene sequencing datasets utilized in this study are publicly available under European Nucleotide Archive (ENA) accession no. ERP109246. The metagenomics data sets, which primarily contain human sequences, are available in the European Genome-phenome Archive (EGA) with managed access (EGAD00001004197).
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Sample size
A power calculation was performed during the planning phase of the Pregnancy Outcome Prediction (POP) study and it is described in Pasupathy et al (BMC Pregnancy and Childbirth 2008 PMID 19019223) . In brief, the sensitivity of different models for a given screen positive rate was quantified by 95% confidence intervals. The calculations indicated that the study was likely to provide reasonably precise estimates of sensitivity for conditions with a 3% incidence, such as severe SGA. The use of a nested case-control design with a 1:1 matching of cases and controls on key maternal characteristics was also planned in advance in the context of very expensive or labor intensive methodologies (Pasupathy et al).
For the 16S rRNA amplicon sequencing study we used 100 matched cases and controls for both pre-eclampsia and growth restriction (ie 200 samples in total). As the effect size was not known in advance we performed power calculations with varying prevalence and effect sizes (OR) for 100 case-control pairs. These showed that a 5% prevalence in controls and OR=5 gives 82% power to detect the signal at significance level 0.05.
Data exclusions A total of 4512 women with a viable singleton pregnancy were recruited to the POP study. The only clinical exclusion criterion was multiple pregnancy.
Replication
Reproducibility of signals was confirmed by analyzing samples both by metagenomic and 16S rRNA amplicon analysis (cohort 1) and by analysing each sample from cohort 2 twice by 16S rRNA amplicon sequencing using 2 different DNA isolation methods. A large part of the manuscript is about proving the reproducibility of signals in order to show which signals are real and which ones are spurious Randomization The POP study is a prospective cohort study of nulliparous women attending the Rosie Hospital (Cambridge, UK) for their dating ultrasound scan. All eligible participants were included.
For the purpose of the experimental projects described in this manuscript, participants were allocated into groups based on pregnancy outcome (details in Methods and Supplementary information). Outcome data were ascertained by review of each woman's paper case record by research midwives and by record linkage to clinical electronic databases. Paired cases and controls were always processed together and sequenced in the same run.
Blinding
All the aspects of the POP study were conducted blind: the results of the research ultrasound scans and the biochemical marker data were not revealed to the clinicians, patients and researchers performing the downstream experiments. Data were unblinded only at the statistical analysis stage. Specifically, all of the bioinformatic analysis of 16S rRNA amplicon data and the metagenomic data was performed in a blinded fashion. Reagent contamination recognition was also performed prior to unblinding. Finally, a statistical analysis plan was written prior to unblinding for the analysis of Streptococcus agalactiae, the only bacterial signal that passed all quality checks for being a genuine and possibly important. All other bacterial analyses (done for all the other bacteria) should be considered exploratory.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
